Medical Health & Life Science Research News

Report explores the global hospital acquired disease testing market

The rising incidence of hospital acquired infections (HAIs) has emerged as a major concern for governments, particularly across developing and underdeveloped countries. In first world countries such as the U.S., various regulations are in place for penalizing hospitals exhibiting a high incidence of HAIs. Such regulations augur well for the hospital acquired disease testing market in developed countries. In contrast, the absence of proper regulations and stringent policies limiting the adoption of molecular-biology-based diagnostics are restricting the expansion of the market across emerging nations.

- Advertising -

The global hospital acquired disease testing market is consolidated due to presence of very few number of players. However, these companies are engaged in high rivalry among themselves, exhibiting in the prevalence of a high degree of competition in the market.

Transparency Market Research (TMR) in a report estimates that the scope for new players is very limited in the competitive landscape of this market. Some of the key players in this market include Thermo Fisher Scientific, Inc., Becton Dickinson and Company, Roche, Abbott Laboratories, and Alere, Inc.

- Advertising -

These companies are striving to capitalize on the emerging opportunities for expansion in the developing countries. These players are strengthening their position in the market while focusing on extensive research and development programs to build innovative hospital acquired disease testing products.

Transparency Market Research has projected that the market value will reach US$2.07 bn by the end of 2023 from its valuation of US$416.7 mn in 2014. The market is anticipated to expand with a healthy CAGR of 19.9% for the forecast period 2015-2023.

View Report at www.transparencymarketresearch.com…ease-testing.html 

In the year 2014, North America emerged as the leading regional market for hospital acquired disease testing, holding nearly 38.5% to the global market. Within the region, the U.S held dominance owing to the increasing number of people suffering from hospital acquired infections.

In the same year, Europe contributed the second largest share in the global market.

Increasing Awareness Regarding HAIs to Propel the Global Market

The increasing incidence of hospital acquired infections (HAI) is one of the key factors propelling the global hospital acquired disease testing market. For the prevention of these infections many countries such as the U.S.

have issued rules and regulations to be mounted in the hospitals and clinics. For instance, the U.S. has regulated HHS Action Plan to reduce infections auqired in hospitals.

These government plans and movements and increasing investments are expected to poise to growth of the global market of hospital acquired disease testing. Furthermore, the rising number of pathogens with drug-resistant abilities is foreseen to help the market expand.

Numerous hospitals around the world are facilitating the pathogen detection procedures with improved surveillance culture. To prevent the transmission of diseases, various health organizations are demanding for effective hospital acquired disease testing solutions.

Factors such as growing concerns about control and prevention of nosocomial infections, increasing number of diseases that increase risk of hospital associated infections, initiatives taken up by governments to manage nosocomial infections, and increasing geriatric population are some of the key factors aiding the market’s expansion. Furthermore, the developing health facilities of developing countries of Asia Pacific are most likely fuel the global hospital acquired disease testing market.

Poor Regulations of Less Developed Countries Could Hinder the Market Growth

The majority of regulations regarding molecular-biology-based diagnostics remain un-updated, which can act as a restraining factor. Furthermore, the absence of control authorities and efficient control programs in less developed countries could hinder the market growth.

For instance, African countries such as Nigeria do not have any effective programs or authority to prevent or control hospital acquired diseases. 

Get accurate market forecast and analysis on the Hospital Acquired Disease Testing Market. Request a sample to stay abreast on the key trends impacting this market.

www.transparencymarketresearch.com…S&rep_id=1759

Nevertheless, the rising health concerns among patients around the world are anticipated to help the market sustain its trajectory and grow over the forecast period. Furthermore, escalating number of urinary tract infection is anticipated fuel the demand for hospital acquires disease testing.

Moreover, the increasing incidence of MRSA, pneumonia, and surgical site infection are expected to boost the market.

This information is taken from the report, “Hospital Acquired Disease Testing Market (Test - Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, and MRSA Infection) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.

This market can be segmented for the categories –

Global Hospital Acquired Disease Testing Market, by Test

  • Pneumonia infection
  • Urinary tract infection
  • Blood stream associated infection
  • Surgical site infection
  • MRSA infection
  • Others

Global Hospital Acquired Disease Testing Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Rest pf APAC
  • Latin America
  • Brazil
  • Rest of LATAM
  • Middle East & Africa
  • Saudi Arabia
  • Rest of MEA

 

News From

Transparency Market Research - In-depth AnalysisTransparency Market Research
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements.      We specialize in the following areas:   Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...